Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial (Q47643599)
Jump to navigation
Jump to search
scientific article published on 30 January 2018
- Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial |
scientific article published on 30 January 2018 |
|
Statements
1 reference
Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial (English)
1 reference
Frederick G Hayden
1 reference
Yaseen M Arabi
1 reference
Adel Alothman
1 reference
Hanan H Balkhy
1 reference
Abdulaziz Al-Dawood
1 reference
Sameera AlJohani
1 reference
Shmeylan Al Harbi
1 reference
Suleiman Kojan
1 reference
Majed Al Jeraisy
1 reference
Abdullah M Assiri
1 reference
Fahad Al-Hameed
1 reference
Asim AlSaedi
1 reference
Yasser Mandourah
1 reference
Ghaleb A Almekhlafi
1 reference
Nisreen Murad Sherbeeni
1 reference
Fatehi Elnour Elzein
1 reference
Javed Memon
1 reference
Yusri Taha
1 reference
Abdullah Almotairi
1 reference
Khalid A Maghrabi
1 reference
Ismael Qushmaq
1 reference
Ali Al Bshabshe
1 reference
Ayman Kharaba
1 reference
Sarah Shalhoub
1 reference
Jesna Jose
1 reference
Robert A Fowler
1 reference
Mohamed A Hussein
1 reference
And the MIRACLE trial group
1 reference
30 January 2018
1 reference
1 reference
19
1 reference
1
1 reference
81
1 reference
30 January 2018
1 reference
Identifiers
1 reference
1 reference
1 reference
1 reference